Anxiousness drug Clonazepam recalled over mislabeling: See lot numbers

23 Nov

Anxiousness drug Clonazepam recalled over mislabeling: See lot numbers


An anxiousness drug is being voluntarily recalled over an error that might be “life-threatening”.

Endo, Inc. issued a voluntary recall for Clonazepam tablets “as a consequence of potential product carton energy mislabeling.” Within the Meals and Drug Administration’s (FDA)recall alert posted on Nov. 19, the pharmaceutical firm is investigating and increasing its beforehand introduced voluntary recall of Clonazepam. The Pennsylvania-based firm issued the primary recall on July 16.  

The image above shows an example of the potential mislabeling.

“Endo’s ongoing investigation has recognized the chance that the Clonazepam product heaps listed beneath include a restricted variety of cartons printed with the wrong energy and Nationwide Drug Code (NDC) code as a consequence of an error by a third-party packager,” the FDA’s alert stated.  

“The blister strips and tablets contained in the product pack mirror the right energy for the lot,” the alert stated.